Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Disruptive Enterprises is a health and wellness company focused on metabolic health and the ketogenic lifestyle. The company develops and markets a portfolio of brands, including KetoLogic and FBOMB, which provide exogenous ketones, high-fat snacks, and nutritional supplements. Their mission is to improve health outcomes through therapeutic nutrition and education on carbohydrate-restricted diets. They operate primarily in the consumer packaged goods (CPG) space with a strong emphasis on science-backed metabolic solutions. The company bridges the gap between clinical research on ketosis and everyday consumer applications for weight loss and performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Disruptive Enterprises.